Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek M Murphy

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Chemistry|May 7, 2014
Enriching mutant sequences by modulating the denaturation time during PCRDerek M Murphy, Elena Castellanos-Rizaldos, G Mike Makrigiorgos
Plos One|July 7, 2011
Co-localization of the oncogenic transcription factor MYCN and the DNA methyl binding protein MeCP2 at genomic sites in neuroblastomaDerek M Murphy, Patrick G Buckley, Sudipto Das, et al.
Carcinogenesis|March 3, 2012
MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathwayJennifer Lynch, Joanna Fay, Maria Meehan, et al.
Cancer Research|September 16, 2010
MicroRNA mediates DNA demethylation events triggered by retinoic acid during neuroblastoma cell differentiationSudipto Das, Niamh Foley, Kenneth Bryan, et al.
Molecular Carcinogenesis|May 11, 2011
Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesisDerek M Murphy, Patrick G Buckley, Kenneth Bryan, et al.
Molecular Cancer|April 23, 2010
MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2Niamh H Foley, Isabella M Bray, Amanda Tivnan, et al.
Plos One|December 10, 2009
Global MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-box motifs and regions of DNA hypermethylationDerek M Murphy, Patrick G Buckley, Kenneth Bryan, et al.
Plos One|November 20, 2009
Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survivalIsabella Bray, Kenneth Bryan, Suzanne Prenter, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Chemistry|May 7, 2014
Enriching mutant sequences by modulating the denaturation time during PCRDerek M Murphy, Elena Castellanos-Rizaldos, G Mike Makrigiorgos
Plos One|July 7, 2011
Co-localization of the oncogenic transcription factor MYCN and the DNA methyl binding protein MeCP2 at genomic sites in neuroblastomaDerek M Murphy, Patrick G Buckley, Sudipto Das, et al.
Carcinogenesis|March 3, 2012
MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathwayJennifer Lynch, Joanna Fay, Maria Meehan, et al.
Cancer Research|September 16, 2010
MicroRNA mediates DNA demethylation events triggered by retinoic acid during neuroblastoma cell differentiationSudipto Das, Niamh Foley, Kenneth Bryan, et al.
Molecular Carcinogenesis|May 11, 2011
Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesisDerek M Murphy, Patrick G Buckley, Kenneth Bryan, et al.
Molecular Cancer|April 23, 2010
MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2Niamh H Foley, Isabella M Bray, Amanda Tivnan, et al.
Plos One|December 10, 2009
Global MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-box motifs and regions of DNA hypermethylationDerek M Murphy, Patrick G Buckley, Kenneth Bryan, et al.
Plos One|November 20, 2009
Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survivalIsabella Bray, Kenneth Bryan, Suzanne Prenter, et al.
Pageof 1